Hepatitis C virus non-structural NS5A protein inhibits epidermal growth factor (EGF)-stimulated activation of the Ras-ERK mitogen-activated protein kinase pathway at a point upstream of Ras activation. To determine the mechanism of this inhibition, the events occurring between the EGF receptor and Ras in Huh-7 cells harbouring the HCV subgenomic replicon were investigated. It was shown that, following EGF stimulation, these cells exhibited decreased EGF receptor tyrosine phosphorylation, aberrant recruitment of the adaptor proteins ShcA and Grb2 to the EGF receptor, reduced phosphorylation of ShcA and reduced Ras activation in comparison with control cells. These data are consistent with effects of NS5A and/or other components of the replicon on multiple events occurring upstream of Ras.
INTRODUCTIONHepatitis C virus (HCV) is the leading cause of liver disease and transplantation in the developing world and is estimated to infect 3 % of the global population (WHO, 1999). More than 80 % of those infected will develop a chronic disease culminating in liver fibrosis, cirrhosis and hepatocellular carcinoma. The HCV genome is a 9?5 kb positive-sense RNA molecule that is translated in a capindependent fashion via an internal ribosome entry site to generate a 3000 residue polypeptide, cleaved by host and viral proteases to produce 10 mature viral proteins.The NS5A protein is one of six non-structural proteins that are believed to form a membrane-bound RNA-replication complex . Further to this role, NS5A has been shown to modulate a range of cellular signalling pathways, including the mitogen-activated protein kinase (MAPK) pathways. In particular, we and others have shown that NS5A expression is able to inhibit the Ras-ERK MAPK pathway (Tan et al., 1999;Georgopoulou et al., 2003;Macdonald et al., 2003). This pathway is activated by growth factors binding to their cognate receptors; this induces autophosphorylation of the receptors on tyrosine residues, which then act as ligands for the Src homology 2 (SH2) domains of adaptor proteins, such as ShcA and Grb2. Grb2 associates with a guanine nucleotideexchange factor, Sos, which induces GDP/GTP exchange on the GTP-binding protein Ras (Tari & Lopez-Berestein, 2001). Ras then binds to and activates a serine kinase, Raf, which triggers a kinase cascade ultimately leading to c-Fos expression and concomitant activation of the AP-1 transcription factor (of which c-Fos is a component). We previously demonstrated that transfection of a dominant-active mutant of Ras was able to override the NS5A-mediated block to this pathway and we therefore concluded that NS5A was acting between the epidermal growth factor receptor (EGFR) and the activation of Ras (Macdonald et al., 2003). The mechanism of this inhibition is unknown, although it has been shown that NS5A is able to bind Grb2 (Tan et al., 1999;, By doing so, it is possible that NS5A might inhibit the formation of the Grb2-Sos complex, thereby breaking the link between the activated EGFR and Ras. However, it has previously been sta...